FDA Inspection 782874 — Al Jazeera Pharmaceutical Industries Company

Al Jazeera Pharmaceutical Industries Company — FEI 3004138409

The FDA completed an inspection of Al Jazeera Pharmaceutical Industries Company on May 8, 2012 in Riyadh. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 5 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 8, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Riyadh (Saudi Arabia)

Citations

IDCFRDescription
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
121521 CFR 211.67(b)Written procedures not established/followed
127421 CFR 211.68(a)Calibration/Inspection/Checking not done
188321 CFR 211.165(a)Testing and release for distribution
203421 CFR 211.194(d)Laboratory equipment calibration records